Project Grant R01AG091773
- Federal Project Grant Award Summary The National Institute on Aging awarded The Washington University $125,000.00 under the Aging Research program (CFDA 93.866) on September 15, 2025, with a completion date of June 30, 2027. This project grant funds scientific research investigating the mechanistic relationship between sleep loss and neurodegeneration, with a specific focus on how epigenetic modifications in microglial responses may influence the progression of tauopathies such as Alzheimer's...
- Federal Project Grant Award Summary Washington State University received a $420,750 Project Grant award dated August 5, 2025, from the National Institute on Aging under the Aging Research program (CFDA 93.866) to conduct research on the reciprocal interactions between sleep disruption, cognitive decline, protein aggregation, and transcriptional processing in an Alzheimer's disease model. The research will extend through July 31, 2027, and utilizes an APP/PS1 transgenic rat model to investigate...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a five-year Project Grant totaling $619,099 to the University of California, Irvine, effective February 1, 2026 through January 31, 2031, under the Aging Research program (CFDA 93.866). The research initiative investigates longitudinal relationships between Alzheimer's Disease (AD) pathophysiology, local sleep expression, and sleep-dependent memory across preclinical disease stages. The project will employ an...
- Federal Grant Award Summary The Salk Institute for Biological Studies received a $785,348 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded on August 15, 2025, with completion targeted for July 31, 2027. This award funds fundamental research investigating the mechanistic relationship between chronic sleep disruption (CSD) and biological aging processes. The research addresses a significant public health concern, as CSD is...
- Federal Grant Award Summary The National Institute on Aging awarded the Regents of the University of Michigan a $107,097 Project Grant effective September 16, 2025, through June 30, 2027, under the Aging Research program (CFDA 93.866). This research project investigates the relationship between sleep disturbances and age-related memory loss by examining how sleep deprivation alters the activity and connectivity of somatostatin-expressing inhibitory interneurons in the hippocampus. The research...
- Federal Grant Award Summary The National Institute on Aging awarded a $464,750 Project Grant to Icahn School of Medicine at Mount Sinai on September 5, 2025, under the Aging Research program (CFDA 93.866). This research project will investigate the differential effects of chronic sleep disruption and intermittent hypoxia in obstructive sleep apnea (OSA) on tau pathology and neuronal spread, with the objective of clarifying how OSA contributes to Alzheimer's disease risk. The primary...
- Federal Project Grant Award Summary The National Institute on Aging awarded a $593,146 Project Grant to Washington University in St. Louis, effective January 1, 2026, through November 30, 2030, under the Aging Research program (CFDA 93.866). This award supports basic scientific research aimed at defining new mechanisms that promote neuronal DNA (deoxyribonucleic acid) repair and transcriptional fidelity across the lifespan. The research addresses a critical gap in understanding how long-lived...
- Summary of Federal Project Grant Award The National Institute on Aging (NIA) awarded The Washington University a $128,373 Project Grant effective August 15, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). This research initiative will develop and compare state-of-the-art biological aging "clock" models across three complementary physiological measurement modalities: epigenetic (DNA methylation), proteomic (protein concentration), and neuroimaging (brain...
- Federal Project Grant Award Summary The National Institute on Aging awarded a $612,005 Project Grant to the University of Pennsylvania on September 15, 2025, under the Aging Research program (CFDA 93.866) to support a research initiative examining sleep slow-wave activity (SWA) as a potential vulnerability and modifiable risk factor in the progression from chronic stress to accelerated aging and Alzheimer's disease in Black older adults. The research will characterize electroencephalogram...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Washington University a $1.85M project grant effective June 1, 2025, through March 31, 2030, under the Aging Research program (CFDA 93.866). The research initiative, titled "First In Last Out: How Development Informs Neurodegeneration," investigates the biological mechanisms linking early brain development to Alzheimer's disease (AD) pathology in later life. The project will deliver empirical research...
The National Institute on Aging (NIA) awarded The Washington University a Project Grant of $578,856 under the Aging Research program (CFDA 93.866) on February 15, 2026, with a completion date of January 31, 2031. This award supports scientific research investigating the relationship between sleep and neurodegenerative disease, with the objective of identifying mechanisms through which sleep reinforces homeostatic set-points in neural activity and determining whether these processes can be augmented to mitigate disease progression. The research will employ novel computational analysis tools applied to continuous, months-long multi-site recordings of neural activity in P301S mice, a tauopathy model, and will evaluate two distinct non-invasive sleep-enhancement methods to bolster homeostatic control of neural criticality—an optimal computational regime that maximizes information processing. The project will deliver quantitative research findings on the relationship between sleep-related patterns of neuronal activity, DNA damage reduction, and neurodegenerative disease progression. Specifically, the research will measure the impact of sleep reinforcement interventions on disease progression and cognitive function in animal models using a sophisticated prey capture task. The deliverables will include empirical data and analysis demonstrating whether reinforcement of criticality through homeostatic sleep enhancement prevents neurodegenerative disease and clarifying the mechanistic pathways through which sleep protects against tauopathy-related neuronal dysfunction.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $578.9k | 2/6/26 |